Babu MM, Priya ML, Selvan AT, Madera M, Gough J, Aravind L, Sankaran K (2006) A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J Bacteriol 188:2761–2773
Article
CAS
Google Scholar
Bastian M, Braun T, Bruns H, Rollinghoff M, Stenger S (2008) Mycobacterial lipopeptides elicit CD4+ CTLs in Mycobacterium tuberculosis-infected humans. J Immunol 180:3436–3446
CAS
Google Scholar
Bessler WG, Ottenbreit BP (1976) Studies on the mitogenic principle of the lipoprotein from the outer membrane of Escherichia coli. Biochem Biophys Res Commun 76:239–246
Article
CAS
Google Scholar
Bessler W, Resch K, Hancock E, Hantke K (1977) Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli. Z Immunitatsforsch Immunobiol 153:11–22
CAS
Google Scholar
Bockenstedt LK, Fikrig E, Barthold SW, Kantor FS, Flavell RA (1993) Inability of truncated recombinant osp a proteins to elicit protective immunity to Borrelia burgdorferi in mice. J Immunol 151:900–906
CAS
Google Scholar
Braun V, Rehn K (1969) Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure. Eur J Biochem 10:426–438
Article
CAS
Google Scholar
Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732–736
Article
CAS
Google Scholar
Bubeck WJ, Williams WA, Missiakas D (2006) Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc Natl Acad Sci USA 103:13831–13836
Article
Google Scholar
Chen HW, Liu SJ, Liu HH, Kwok Y, Lin CL, Lin LH, Chen MY, Tsai JP, Chang LS, Chiu FF, Lai LW, Lian WC, Yang CY, Hsieh SY, Chong P, Leng CH (2009) A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design. Vaccine 27:1400–1409
Article
CAS
Google Scholar
Cote-Sierra J, Jongert E, Bredan A, Gautam DC, Parkhouse M, Cornelis P, De Baetselier P, Revets H (1998) A new membrane-bound opri lipoprotein expression vector. High production of heterologous fusion proteins in gram (−) bacteria and the implications for oral vaccination. Gene 221:25–34
Article
CAS
Google Scholar
Cullen PA, Lo M, Bulach DM, Cordwell SJ, Adler B (2003) Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid 49:18–29
Article
CAS
Google Scholar
Drage MG, Pecora ND, Hise AG, Febbraio M, Silverstein RL, Golenbock DT, Boom WH, Harding CV (2009) TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell Immunol 258:29–37
Article
CAS
Google Scholar
Fikrig E, Barthold SW, Kantor FS, Flavell RA (1990) Protection of mice against the lyme disease agent by immunizing with recombinant OspA. Science 250:553–556
Article
CAS
Google Scholar
Gupta SD, Gan K, Schmid MB, Wu HC (1993) Characterization of a temperature-sensitive mutant of Salmonella typhimurium defective in apolipoprotein N-acyltransferase. J Biol Chem 268:16551–16556
CAS
Google Scholar
Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, Wagar EA (1999) Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 67:6572–6582
CAS
Google Scholar
Hanson MS, Hansen EJ (1991) Molecular cloning, partial purification, and characterization of a haemin-binding lipoprotein from Haemophilus influenzae type b. Mol Microbiol 5:267–278
Article
CAS
Google Scholar
Hansson L, Noppa L, Nilsson AK, Stromqvist M, Bergstrom S (1995) Expression of truncated and full-length forms of the Lyme disease Borrelia outer surface protein a in Escherichia coli. Protein Expr Purif 6:15–24
Article
CAS
Google Scholar
Hayashi S, Wu HC (1990) Lipoproteins in bacteria. J Bioenerg Biomembr 22:451–471
Article
CAS
Google Scholar
Heyde M, Coll JL, Portalier R (1991) Identification of Escherichia coli genes whose expression increases as a function of external pH. Mol Gen Genet 229:197–205
Article
CAS
Google Scholar
Ignatova Z, Mahsunah A, Georgieva M, Kasche V (2003) Improvement of posttranslational bottlenecks in the production of penicillin amidase in recombinant Escherichia coli strains. Appl Environ Microbiol 69:1237–1245
Article
CAS
Google Scholar
Jackowski S, Rock CO (1986) Transfer of fatty acids from the 1-position of phosphatidylethanolamine to the major outer membrane lipoprotein of Escherichia coli. J Biol Chem 261:11328–11333
CAS
Google Scholar
Johnson BJ, Sviat SL, Happ CM, Dunn JJ, Frantz JC, Mayer LW, Piesman J (1995) Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2. Vaccine 13:1086–1094
Article
CAS
Google Scholar
Lancioni CL, Li Q, Thomas JJ, Ding X, Thiel B, Drage MG, Pecora ND, Ziady AG, Shank S, Harding CV, Boom WH, Rojas RE (2011) Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2. Infect Immun 79:663–673
Article
CAS
Google Scholar
Lugade AA, Bianchi-Smiraglia A, Pradhan V, Elkin G, Murphy TF, Thanavala Y (2011) Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling. PLoS One 6:e19781
Article
CAS
Google Scholar
Luo D, Xue F, Ojcius DM, Zhao J, Mao Y, Li L, Lin X, Yan J (2009) Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine 28:243–255
Article
Google Scholar
Malouin F, Chamberland S, Brochu N, Parr TR Jr (1991) Influence of growth media on Escherichia coli cell composition and ceftazidime susceptibility. Antimicrob Agents Chemother 35:477–483
CAS
Google Scholar
Melchers F, Braun V, Galanos C (1975) The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med 142:473–482
Article
CAS
Google Scholar
Padan E, Zilberstein D, Rottenberg H (1976) The proton electrochemical gradient in Escherichia coli cells. Eur J Biochem 63:533–541
Article
CAS
Google Scholar
Pajon R, Yero D, Niebla O, Climent Y, Sardinas G, Garcia D, Perera Y, Llanes A, Delgado M, Cobas K, Caballero E, Taylor S, Brookes C, Gorringe A (2009) Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes. Vaccine 28:532–541
Article
CAS
Google Scholar
Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV (2006) Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol 177:422–429
CAS
Google Scholar
Philipp MT, Lobet Y, Bohm RP Jr, Roberts ED, Dennis VA, Gu Y, Lowrie RC Jr, Desmons P, Duray PH, England JD, Hauser P, Piesman J, Xu K (1997) The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine 15:1872–1887
Article
CAS
Google Scholar
Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816–1820
Article
CAS
Google Scholar
Sankaran K, Wu HC (1994) Lipid modification of bacterial prolipoprotein. Transfer of diacylglyceryl moiety from phosphatidylglycerol. J Biol Chem 269:19701–19706
CAS
Google Scholar
Schenk M, Belisle JT, Modlin RL (2009) TLR2 looks at lipoproteins. Immunity 31:847–849
Article
CAS
Google Scholar
Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, Santini L, Biolchi A, Seib KL, Giuliani MM, Donnelly JJ, Berti F, Savino S, Scarselli M, Costantino P, Kroll JS, O’Dwyer C, Qiu J, Plaut AG, Moxon R, Rappuoli R, Pizza M, Aricò B (2010) Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci USA 107:3770–3775
Article
CAS
Google Scholar
Shang ES, Summers TA, Haake DA (1996) Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 64:2322–2330
CAS
Google Scholar
Slonczewski JL, Rosen BP, Alger JR, Macnab RM (1981) pH homeostasis in Escherichia coli: Measurement by 31P nuclear magnetic resonance of methylphosphonate and phosphate. Proc Natl Acad Sci USA 78:6271–6275
Article
CAS
Google Scholar
Stoll H, Dengjel J, Nerz C, Gotz F (2005) Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun 73:2411–2423
Article
CAS
Google Scholar
Sung JW, Hsieh SY, Lin CL, Leng CH, Liu SJ, Chou AH, Lai LW, Lin LH, Kwok Y, Yang CY, Chong P (2010) Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B. Vaccine 28:8175–8182
Article
CAS
Google Scholar
Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Bolcskei PL, Wagner M, Akira S, Norgard MV, Belisle JT, Godowski PJ, Bloom BR, Modlin RL (2001) Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291:1544–1547
Article
CAS
Google Scholar
Tokunaga M, Tokunaga H, Wu HC (1982) Post-translational modification and processing of Escherichia coli prolipoprotein in vitro. Proc Natl Acad Sci USA 79:2255–2259
Article
CAS
Google Scholar
Tucker DL, Tucker N, Conway T (2002) Gene expression profiling of the pH response in Escherichia coli. J Bacteriol 184:6551–6558
Article
CAS
Google Scholar
Ujihara T, Sakurai I, Mizusawa N, Wada H (2008) A method for analyzing lipid-modified proteins with mass spectrometry. Anal Biochem 374:429–431
Article
CAS
Google Scholar
van Mellaert L, Anne J (2001) Gram-positive bacteria as host cells for heterologous production of biopharmaceuticals. In: van Broekhoven A, Shapior F, Anne J (eds) Novel frontiers in the production of compounds for biomedical use. Kluwer Academic Publishers, Dordrecht, pp 277–300
Google Scholar
Zilberstein D, Agmon V, Schuldiner S, Padan E (1984) Escherichia coli intracellular pH, membrane potential, and cell growth. J Bacteriol 158:246–252
CAS
Google Scholar